ConductScience.org, home

Paper6133544

Benzodiazepines impair smooth pursuit eye movements.

Bittencourt PR and 3 others. Br J Clin Pharmacol, 1983. Cited by 51 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Benzodiazepines impair smooth pursuit eye movements. Papers, record 6133544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6133544

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Benzodiazepines impair smooth pursuit eye movements.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
2.45
iCite
Revised in PubMed
2022-04-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bittencourt PRP R
2Wade PP
3Smith ATA T
4Richens AA

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Anxiety AgentsMajor topic
DiazepamMajor topic
Eye MovementsMajor topic
TemazepamMajor topic
Adult
Double-Blind Method
Humans
Male
Random Allocation

Source PubMed

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,734,522[The effect of diazepam (Valium) on the saccadic eye movements in man].Arch Psychiatr Nervenkr (1970)1968https://conductscience.org/library/papers/5734522PubMed
26,794,587The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6794587PubMed
35,093,959The action of sedatives on brain stem oculomotor systems in man.Neuropharmacology1971https://conductscience.org/library/papers/5093959PubMed
44,711,736Eye-tracking patterns in schizophrenia.Science1973https://conductscience.org/library/papers/4711736PubMed
54,204,764Benzodiazepines in the treatment of epilepsy. A review.Epilepsia1973https://conductscience.org/library/papers/4204764PubMed
64,815,224Cross-national study of the extent of anti-anxiety/sedative drug use.N Engl J Med1974https://conductscience.org/library/papers/4815224PubMed
71,105,630Smooth-pursuit eye movements, and diazepam, CPZ, and secobarbital.Psychopharmacologia1975https://conductscience.org/library/papers/1105630PubMed
81,244,754Determination of 1,4-benzodiazepines and -diazepin-2-ones in blood by electron-capture gas-liquid chromatography.Anal Chem1976https://conductscience.org/library/papers/1244754PubMed
97,375Blood levels and electroencephalographic effects of diazepam and bromazepam.Clin Pharmacol Ther1976https://conductscience.org/library/papers/7375PubMed
10299,996Eye-tracking and optokinetic nystagmus. Results of quantitative testing in patients with well-defined nervous system lesions.Ann Otol Rhinol Laryngol1977https://conductscience.org/library/papers/299996PubMed
1114,659Plasma concentrations of benzodiazepines.Br J Clin Pharmacol1977https://conductscience.org/library/papers/14659PubMed
12304,721Vision during angular oscillation: the dynamic interaction of visual and vestibular mechanisms.Aviat Space Environ Med1978https://conductscience.org/library/papers/304721PubMed
13305,272Disorders of the vestibulo-ocular reflex producing oscillopsia and mechanisms compensating for loss of labyrinthine function.Brain1977https://conductscience.org/library/papers/305272PubMed
14346,285Clinical pharmacokinetics of diazepam.Clin Pharmacokinet1978https://conductscience.org/library/papers/346285PubMed
15359,017Immediate and residual effects in man of the metabolites of diazepam.Br J Clin Pharmacol1978https://conductscience.org/library/papers/359017PubMed
1631,354Pitfalls and prospects in clinical research on antianxiety drugs: benzodiazepines and placebo--a research review.J Clin Psychiatry1978https://conductscience.org/library/papers/31354PubMed
1734,097Sleeping pills, insomnia and medical practice.N Engl J Med1979https://conductscience.org/library/papers/34097PubMed
1835,267Minor tranquillisers and road accidents.Br Med J1979https://conductscience.org/library/papers/35267PubMed
196,102,508Benzodiazepines: clinical pharmacology and therapeutic use.Drugs1980https://conductscience.org/library/papers/6102508PubMed
207,425,559Optokinetic nystagmus and parietal lobe lesions.Ann Neurol1980https://conductscience.org/library/papers/7425559PubMed

See all 23 references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
41,148,790Biomarker-Based Pharmacological Characterization of ENX-102, a Novel α2/3/5 Subtype-Selective GABAA Receptor Positive Allo-Steric Modulator: Translational Insights from Rodent and Human Studies.Cells2025https://conductscience.org/library/papers/41148790PubMed
40,836,528Cannabidiol Lacks Direct Effect on Cortical Excitability: A Randomized, Double Blind, Placebo Controlled, 3-Way Crossover Trial.Clin Pharmacol Ther2026https://conductscience.org/library/papers/40836528PubMed
40,109,754Application of a Nociceptive Test Battery to Assess Potential Synergy between Two Analgesics in Healthy Subjects.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40109754PubMed
39,898,464CB1 Receptor Antagonist Selonabant (ANEB-001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled Trial.Clin Pharmacol Ther2025https://conductscience.org/library/papers/39898464PubMed
37,118,895First-in-human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulator.Clin Transl Sci2023https://conductscience.org/library/papers/37118895PubMed
36,730,178Fit for purpose of on-the-road driving and simulated driving: A randomised crossover study using the effect of sleep deprivation.PLoS One2023https://conductscience.org/library/papers/36730178PubMed
36,153,330Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers.Transl Psychiatry2022https://conductscience.org/library/papers/36153330PubMed
35,995,080Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review.Neurosci Biobehav Rev2022https://conductscience.org/library/papers/35995080PubMed
35,014,069Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers.Br J Clin Pharmacol2022https://conductscience.org/library/papers/35014069PubMed
34,021,607Biperiden Challenge Model in Healthy Elderly as Proof-of-Pharmacology Tool: A Randomized, Placebo-Controlled Trial.J Clin Pharmacol2021https://conductscience.org/library/papers/34021607PubMed
33,083,515Safety, pharmacokinetics, and pharmacodynamics of Gln-1062, a prodrug of galantamine.Alzheimers Dement (N Y)2020https://conductscience.org/library/papers/33083515PubMed
30,984,817No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model.Alzheimers Dement (N Y)2019https://conductscience.org/library/papers/30984817PubMed
30,710,391Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers.Br J Clin Pharmacol2019https://conductscience.org/library/papers/30710391PubMed
29,067,291First in human study with a prodrug of galantamine: Improved benefit-risk ratio?Alzheimers Dement (N Y)2016https://conductscience.org/library/papers/29067291PubMed
28,217,868An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.Br J Clin Pharmacol2017https://conductscience.org/library/papers/28217868PubMed
23,067,311Pharmacokinetics and central nervous system effects of the novel dual NK1 /NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers.Br J Clin Pharmacol2013https://conductscience.org/library/papers/23067311PubMed
20,443,647Ocular adverse effects of common psychotropic agents: a review.CNS Drugs2010https://conductscience.org/library/papers/20443647PubMed
19,843,056Central nervous system effects of alcohol at a pseudo-steady-state concentration using alcohol clamping in healthy volunteers.Br J Clin Pharmacol2009https://conductscience.org/library/papers/19843056PubMed
19,028,266Pharmacological treatment effects on eye movement control.Brain Cogn2008https://conductscience.org/library/papers/19028266PubMed
14,513,188Effects of diazepam on closed- and open-loop optokinetic nystagmus (OKN) in humans.Exp Brain Res2003https://conductscience.org/library/papers/14513188PubMed

See all 28 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6133544

GET https://conductscience.org/api/papers/v1/6133544/references?page=2